| Literature DB >> 32139372 |
Abstract
In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features. © Royal College of Physicians 2020. All rights reserved.Entities:
Keywords: 2019-nCoV; SARS-CoV-2; Wuhan; coronavirus; respiratory tract infection
Mesh:
Year: 2020 PMID: 32139372 PMCID: PMC7081812 DOI: 10.7861/clinmed.2019-coron
Source DB: PubMed Journal: Clin Med (Lond) ISSN: 1470-2118 Impact factor: 2.659